Foreword

Therapy of lymphoma is complex. The myriad clinical presentations, histologies, and molecular signatures have permitted—some would say forced—us to segment this disease into an indistinct mass of almost unique entities. Doctors Wilson and Smith, in this issue of Current Problems in Cancer, have taken the first step of recognizing that the cutaneous lymphomas represent a unique cohort of diseases that, despite their differences, may be considered within a coherent scheme. That view may be the first step to a new overarching clinical consideration of lymphoma in general. This review is essential for those of us with infrequent exposure to such patients.

Few clinics have the breadth of cutaneous lymphoma experience as the Yale group; when the topic was agreed upon for this year’s schedule, the choice of authorship was obvious. This monograph is proof that the choice was well made.